FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4221062384> ?p ?o ?g. }

• W4221062384 abstract "Keluoxin (KLX) is an active agent in the treatment of diabetic retinopathy (DR). However, its mechanism, targets, and effective constituents against DR are still unclear, which seriously restricts its clinical application. Chinmedomics has the promise of explaining the pharmacological effects of herbal medicines and investigating the effective mechanisms. The research results from electroretinography and electron microscope showed that KLX could reduce retinal dysfunction and pathological changes by the DR mouse model. Based on effectiveness, we discovered 64 blood biomarkers of DR by nontargeted metabolomics analysis, 51 of which returned to average levels after KLX treatment including leukotriene D4 and A4, l-tryptophan, 6-hydroxymelatonin, l-phenylalanine, l-tyrosine, and gamma-linolenic acid (GLA). The metabolic pathways involved were phenylalanine metabolism, steroid hormone biosynthesis, sphingolipid metabolism, etc. Adenosine monophosphate-activated protein kinase (AMPK), extracellular signal-regulated protein kinase1/2 (ERK1/2), phosphatidylinositol-3-kinase (PI3K), and protein 70 S6 kinase (p70 S6K) might be potential targets of KLX against DR. This was related to the mammalian target of rapamycin (mTOR) signaling and AMPK signaling pathways. We applied the chinmedomics strategy, integrating serum pharm-chemistry of traditional Chinese medicine (TCM) with metabolomics, to discover astragaloside IV (AS-IV), emodin, rhein, chrysophanol, and other compounds, which were the core effective constituents of KLX when against DR. Our study was the first to apply the chinmedomics strategy to discover the effective constituents of KLX in the treatment of DR, which fills the gap of unclear effective constituents of KLX. In the next step, the research of effective constituents can be used to optimize prescription preparation, improve the quality standard, and develop an innovative drug." @default.
• W4221062384 created "2022-04-03" @default.
• W4221062384 creator A5011877804 @default.
• W4221062384 creator A5015578891 @default.
• W4221062384 creator A5024142927 @default.
• W4221062384 creator A5028774110 @default.
• W4221062384 creator A5030670609 @default.
• W4221062384 creator A5037595509 @default.
• W4221062384 creator A5053957639 @default.
• W4221062384 date "2022-03-31" @default.
• W4221062384 modified "2023-10-05" @default.
• W4221062384 title "Chinmedomics Strategy for Elucidating the Pharmacological Effects and Discovering Bioactive Compounds From Keluoxin Against Diabetic Retinopathy" @default.
• W4221062384 cites W1517336748 @default.
• W4221062384 cites W1873160384 @default.
• W4221062384 cites W1967878668 @default.
• W4221062384 cites W2005226793 @default.
• W4221062384 cites W2026428328 @default.
• W4221062384 cites W2044058221 @default.
• W4221062384 cites W2062862527 @default.
• W4221062384 cites W2091106598 @default.
• W4221062384 cites W2101242243 @default.
• W4221062384 cites W2107674876 @default.
• W4221062384 cites W2111444803 @default.
• W4221062384 cites W2120339105 @default.
• W4221062384 cites W2121080481 @default.
• W4221062384 cites W2124831341 @default.
• W4221062384 cites W2136122793 @default.
• W4221062384 cites W2159664830 @default.
• W4221062384 cites W2162340300 @default.
• W4221062384 cites W2221603408 @default.
• W4221062384 cites W2224206458 @default.
• W4221062384 cites W2225695586 @default.
• W4221062384 cites W2227154220 @default.
• W4221062384 cites W2342880967 @default.
• W4221062384 cites W2399586521 @default.
• W4221062384 cites W2523648925 @default.
• W4221062384 cites W2550276097 @default.
• W4221062384 cites W2566978771 @default.
• W4221062384 cites W2571981357 @default.
• W4221062384 cites W2591751219 @default.
• W4221062384 cites W2613414011 @default.
• W4221062384 cites W2744602602 @default.
• W4221062384 cites W2765322183 @default.
• W4221062384 cites W2765820973 @default.
• W4221062384 cites W2777882786 @default.
• W4221062384 cites W2779569961 @default.
• W4221062384 cites W2794416320 @default.
• W4221062384 cites W2794677028 @default.
• W4221062384 cites W2795590036 @default.
• W4221062384 cites W2797026917 @default.
• W4221062384 cites W2855216278 @default.
• W4221062384 cites W2884988665 @default.
• W4221062384 cites W2894399138 @default.
• W4221062384 cites W2899405235 @default.
• W4221062384 cites W2901637823 @default.
• W4221062384 cites W2902905490 @default.
• W4221062384 cites W2904835522 @default.
• W4221062384 cites W2937321763 @default.
• W4221062384 cites W2938820474 @default.
• W4221062384 cites W2947533150 @default.
• W4221062384 cites W2949045629 @default.
• W4221062384 cites W2965008727 @default.
• W4221062384 cites W2965888264 @default.
• W4221062384 cites W2977071875 @default.
• W4221062384 cites W2990744049 @default.
• W4221062384 cites W2991334856 @default.
• W4221062384 cites W2997262461 @default.
• W4221062384 cites W2998439854 @default.
• W4221062384 cites W2999473311 @default.
• W4221062384 cites W2999536993 @default.
• W4221062384 cites W2999819814 @default.
• W4221062384 cites W3008252224 @default.
• W4221062384 cites W3012240835 @default.
• W4221062384 cites W3017197392 @default.
• W4221062384 cites W3020397684 @default.
• W4221062384 cites W3032338644 @default.
• W4221062384 cites W3034942882 @default.
• W4221062384 cites W3046155618 @default.
• W4221062384 cites W3083228456 @default.
• W4221062384 cites W3084666114 @default.
• W4221062384 cites W3087177447 @default.
• W4221062384 cites W3088710303 @default.
• W4221062384 cites W3088975969 @default.
• W4221062384 cites W3089576524 @default.
• W4221062384 cites W3092387820 @default.
• W4221062384 cites W3092532329 @default.
• W4221062384 cites W3096174763 @default.
• W4221062384 cites W3106751699 @default.
• W4221062384 cites W3110220146 @default.
• W4221062384 cites W3115132313 @default.
• W4221062384 cites W3127697230 @default.
• W4221062384 cites W4211205882 @default.
• W4221062384 doi "https://doi.org/10.3389/fphar.2022.728256" @default.
• W4221062384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35431942" @default.
• W4221062384 hasPublicationYear "2022" @default.
• W4221062384 type Work @default.
• W4221062384 citedByCount "8" @default.
• W4221062384 countsByYear W42210623842022 @default.
• W4221062384 countsByYear W42210623842023 @default.
• W4221062384 crossrefType "journal-article" @default.

• next